273 related articles for article (PubMed ID: 35042018)
1. Metabolomics as a promising tool for improving understanding of multiple sclerosis: A review of recent advances.
Liu Z; Waters J; Rui B
Biomed J; 2022 Aug; 45(4):594-606. PubMed ID: 35042018
[TBL] [Abstract][Full Text] [Related]
2. An emerging potential of metabolomics in multiple sclerosis: a comprehensive overview.
Zahoor I; Rui B; Khan J; Datta I; Giri S
Cell Mol Life Sci; 2021 Apr; 78(7):3181-3203. PubMed ID: 33449145
[TBL] [Abstract][Full Text] [Related]
3. Contribution of Metabolomics to Multiple Sclerosis Diagnosis, Prognosis and Treatment.
Rispoli MG; Valentinuzzi S; De Luca G; Del Boccio P; Federici L; Di Ioia M; Digiovanni A; Grasso EA; Pozzilli V; Villani A; Chiarelli AM; Onofrj M; Wise RG; Pieragostino D; Tomassini V
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681773
[TBL] [Abstract][Full Text] [Related]
4. Metabolome-based signature of disease pathology in MS.
Andersen SL; Briggs FBS; Winnike JH; Natanzon Y; Maichle S; Knagge KJ; Newby LK; Gregory SG
Mult Scler Relat Disord; 2019 Jun; 31():12-21. PubMed ID: 30877925
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics in multiple sclerosis disease course and progression.
Bhargava P; Anthony DC
Mult Scler; 2020 Apr; 26(5):591-598. PubMed ID: 31965880
[TBL] [Abstract][Full Text] [Related]
6. NMR-based metabolomics identification of potential serum biomarkers of disease progression in patients with multiple sclerosis.
Alwahsh M; Nimer RM; Dahabiyeh LA; Hamadneh L; Hasan A; Alejel R; Hergenröder R
Sci Rep; 2024 Jun; 14(1):14806. PubMed ID: 38926483
[TBL] [Abstract][Full Text] [Related]
7. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.
Singh J; Cerghet M; Poisson LM; Datta I; Labuzek K; Suhail H; Rattan R; Giri S
J Neuroimmune Pharmacol; 2019 Jun; 14(2):241-250. PubMed ID: 30315511
[TBL] [Abstract][Full Text] [Related]
8. Identification of Altered Metabolic Pathways during Disease Progression in EAE Mice via Metabolomics and Lipidomics.
Lee G; Hasan M; Kwon OS; Jung BH
Neuroscience; 2019 Sep; 416():74-87. PubMed ID: 31376423
[TBL] [Abstract][Full Text] [Related]
9. A Urinary Metabolic Signature for Multiple Sclerosis and Neuromyelitis Optica.
Gebregiworgis T; Nielsen HH; Massilamany C; Gangaplara A; Reddy J; Illes Z; Powers R
J Proteome Res; 2016 Feb; 15(2):659-66. PubMed ID: 26759122
[TBL] [Abstract][Full Text] [Related]
10. Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis.
Poddighe S; Murgia F; Lorefice L; Liggi S; Cocco E; Marrosu MG; Atzori L
Int J Biochem Cell Biol; 2017 Dec; 93():148-155. PubMed ID: 28720279
[TBL] [Abstract][Full Text] [Related]
11. Metabolomics in multiple sclerosis.
Bhargava P; Calabresi PA
Mult Scler; 2016 Apr; 22(4):451-60. PubMed ID: 26754801
[TBL] [Abstract][Full Text] [Related]
12. Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicine.
Del Boccio P; Rossi C; di Ioia M; Cicalini I; Sacchetta P; Pieragostino D
Proteomics Clin Appl; 2016 Apr; 10(4):470-84. PubMed ID: 27061322
[TBL] [Abstract][Full Text] [Related]
13. Brain energy metabolism and multiple sclerosis: progress and prospects.
Park SJ; Choi JW
Arch Pharm Res; 2020 Oct; 43(10):1017-1030. PubMed ID: 33119885
[TBL] [Abstract][Full Text] [Related]
14. Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation.
Bhargava P; Fitzgerald KC; Calabresi PA; Mowry EM
JCI Insight; 2017 Oct; 2(19):. PubMed ID: 28978801
[TBL] [Abstract][Full Text] [Related]
15. Recent advances and perspectives of metabolomics-based investigations in Parkinson's disease.
Shao Y; Le W
Mol Neurodegener; 2019 Jan; 14(1):3. PubMed ID: 30634989
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometric based approaches in urine metabolomics and biomarker discovery.
Khamis MM; Adamko DJ; El-Aneed A
Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008
[TBL] [Abstract][Full Text] [Related]
17. Proteomic Approaches to Decipher Mechanisms Underlying Pathogenesis in Multiple Sclerosis Patients.
Singh V; Tripathi A; Dutta R
Proteomics; 2019 Aug; 19(16):e1800335. PubMed ID: 31119864
[TBL] [Abstract][Full Text] [Related]
18. Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism.
Fitzgerald KC; Smith MD; Kim S; Sotirchos ES; Kornberg MD; Douglas M; Nourbakhsh B; Graves J; Rattan R; Poisson L; Cerghet M; Mowry EM; Waubant E; Giri S; Calabresi PA; Bhargava P
Cell Rep Med; 2021 Oct; 2(10):100424. PubMed ID: 34755135
[TBL] [Abstract][Full Text] [Related]
19. NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review.
Smolinska A; Blanchet L; Buydens LM; Wijmenga SS
Anal Chim Acta; 2012 Oct; 750():82-97. PubMed ID: 23062430
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
